OR WAIT 15 SECS
January 13, 2021
Biopharma sustainability resolutions for a better 2021.
December 11, 2020
For many years, high energy use and its impact on the environment by businesses within the life sciences sector had been generally overlooked in national and global efforts to combat climate change. But with “carbon neutrality” the new buzzwords, how is the sector embracing this push for change?
Why major companies are stepping up environmental commitments.
November 16, 2020
SynBio opens new environmental sustainability possibilities for pharma.
Especially critical amid the continuing global pandemic, key metrics are laid out to help life sciences companies define, measure, and effectively communicate sustainability practices and progress—and build foundations for long-term business value.
October 14, 2020
Biopharma must find sustainable models for public policy engagement.
September 11, 2020
ESG objectives are integral to long-term biopharma strategy.
August 07, 2020
The need for clear transparency around use of real-world data, AI.
July 07, 2020
Three areas critical to ensuring meaningful long-term action.
June 12, 2020
Guidance addresses struggles in reporting non-financial performance.
